Drug

Who makes brexpiprazole?

3 companies list brexpiprazole as a human prescription drug, including under the names Rexulti. Forms: kit; tablet. Routes: oral.

Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology

Companies listing brexpiprazole

CompanyFormsApplicationNDCsRegistered sites
Otsuka America Pharmaceutical, Inc.Japankit; tabletNDANDA20542286
Ajanta Pharma LimitedIndiatabletANDAANDA21371862
RemedyRepack, IncUnited StatestabletNDANDA20542221

Bulk ingredient listings

Orange Book patents

7 unexpired patents list brexpiprazole as the active ingredient, expiring between Oct 2026 and Apr 2033. Application holder: OTSUKA PHARMACEUTICAL CO LTD.

Enquiry

Common questions

Who makes brexpiprazole?
3 companies list brexpiprazole as a human prescription drug in the openFDA NDC Directory, led by Otsuka America Pharmaceutical, Inc., Ajanta Pharma Limited, RemedyRepack, Inc. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
Is there a generic Rexulti?
1 company lists brexpiprazole under an abbreviated new drug application (ANDA), the application type used for generics, and 2 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.
Who supplies brexpiprazole active ingredient?
10 companies list brexpiprazole as a bulk ingredient, including Aurobindo Pharma Limited, Honour Lab Limited, Jubilant Biosys Limited, MSN Life Sciences Private Limited.